[Risk-adapted multimodal laboratory cervical screening---Pap test of the future?].
[Risk-adapted multimodal laboratory cervical screening---Pap test of the future?].
复制标题
[适应风险的多模式实验室宫颈筛查——未来的巴氏试验？]。
DOI：
10.1007/s00292-007-0923-9
复制
发表时间：
2007
期刊：
影响因子：
--
通讯作者：
M. Bollmann
中科院分区：
文献类型：
--
作者：
R. Bollmann;A. Várnai;A. Bankfalvi;M. Bollmann
宫颈癌筛查的目的是降低死亡率和发病率。到目前为止，有广泛而有力的证据表明，这可以通过基于细胞学的筛查计划来实现，尽管其固有的方法学局限性，但该计划仍然是世界范围内宫颈预防的支柱。本文综述了宫颈筛查的常规方法、辅助方法和实验方法作为单项检查和联合检查的实用性，并描述了使用风险适应方案提高筛查准确性的可能的未来方向。
The objective of screening for cervical cancer is to reduce mortality and incidence of the disease. To date there is extensive and strong evidence that this can be achieved by cytology-based screening programs, which continue to be the mainstay of cervical prevention worldwide despite their inherent methodological limitations. This article presents a review on the utility of conventional, ancillary and experimental methods for cervical screening both as single tests and test combinations, and describes possible future directions for enhanced screening accuracy using risk-adapted protocols.